Weight Loss and Wellness Services
GENERAL CONSENT TO TREATMENT
I, the undersigned, voluntarily consent to medical evaluation, treatment, and procedures performed by the providers and staff of Precision Metabolic Health, I understand that:
1. No guarantee of specific results has been made.
2. I have the right to refuse or discontinue treatment at any time.
3. My treatment plan will be developed collaboratively with my provider.
4. I am expected to participate actively in my care, including follow-up visits and lifestyle modifications.
MEDICATION CONSENT – GLP-1 RECEPTOR AGONISTS
If GLP-1 medications (such as semaglutide or tirzepatide) are prescribed, I understand and acknowledge:
• Common side effects include nausea, vomiting, diarrhea, constipation, and decreased appetite.
• Rare but serious risks include pancreatitis, gallbladder disease, and kidney problems.
• These medications carry a boxed warning for thyroid C-cell tumors in animal studies; I will inform my provider if I have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
• I will not use GLP-1 medications if I am pregnant, planning to become pregnant, or breastfeeding.
• I must attend required follow-up appointments for monitoring.
• I will report any unusual symptoms to my provider promptly.
• Insurance may not cover this medication and I accept financial responsibility.
MEDICATION CONSENT – PEPTIDE THERAPY
Peptide therapies (such as BPC-157, CJC-1295, Ipamorelin, AOD-9604, and others) may be offered as part of your individualized wellness and weight loss plan. These are compounds that signal various biological pathways related to metabolism, recovery, and body composition. If peptide therapy is prescribed, I understand and
acknowledge the following:
• Regulatory status: Many peptides are compounded medications and are not FDA-approved for the specific indications for which they may be prescribed. Their use is considered off-label. I have been informed of this status and consent to off-label use as part of my individualized treatment plan.
• Compounding pharmacy: Peptides prescribed at this clinic are sourced from licensed, accredited compounding pharmacies. I understand that compounded medications are not subject to the same pre-market approval process as commercially manufactured drugs.
• Possible side effects: Depending on the specific peptide(s) prescribed, side effects may include injection site reactions (redness, swelling, bruising), water retention, fatigue, headache, tingling or numbness, changes in blood sugar, and, for growth hormone secretagogues, potential effects on cortisol or prolactin levels. I will report any adverse reactions to my provider promptly.
• Administration: Peptide therapies are typically self-administered via subcutaneous injection. I will receive
thorough instruction on proper injection technique, storage, and disposal before beginning therapy. I agree to follow all administration instructions as directed.
• Contraindications: I have disclosed all known medical conditions, prior cancers, hormone-sensitive conditions, and current medications. I understand that active malignancy or a history of certain cancers may be a contraindication to growth hormone-stimulating peptides, and my provider has evaluated my
suitability for therapy.
• Monitoring: Baseline and follow-up labs (which may include IGF-1, fasting glucose, lipid panel, and others as clinically indicated) may be required to monitor my response to therapy. I agree to complete all ordered laboratory tests.
• Pregnancy and breastfeeding: I will notify my provider immediately if I am pregnant, planning to become pregnant, or breastfeeding, as peptide therapy is generally not recommended during these periods.
• Insurance coverage: Peptide therapies are typically not covered by insurance and are billed as cash-pay services. I accept full financial responsibility for peptide therapy costs. I understand that no guarantee of specific outcomes has been made.